AAAAAA

   
Results: 1-25 |
Results: 25

Authors: GUILLOTEAU D EMOND P BAULIEU JL GARREAU L FRANGIN Y POURCELOT L MAUCLAIRE L BESNARD JC CHALON S
Citation: D. Guilloteau et al., EXPLORATION OF THE DOPAMINE TRANSPORTER - IN-VITRO AND IN-VIVO CHARACTERIZATION OF A HIGH-AFFINITY AND HIGH-SPECIFICITY IODINATED TROPANE DERIVATIVE TA-CARBOMETHOXY-3-BETA-(4'-METHYLPHENYL)NORTROPANE (PE2I), Nuclear medicine and biology, 25(4), 1998, pp. 331-337

Authors: ZIMMER L EMOND P FRANGIN Y CHALON S BESNARD JC GUILLOTEAU D
Citation: L. Zimmer et al., SPECIFICITY OF PE2I, ANEW COCAINE DERIVATE FOR DOPAMINE TRANSPORTER IMAGING - AN IN-VIVO STUDY BY DUAL-PROBE MICRODIALYSIS, The Journal of nuclear medicine, 39(5), 1998, pp. 187-187

Authors: SANDELL J HELFENBEIN J HALLDIN C OKUBO Y CHALON S FRANGIN Y GALINIER E SWAHN CG GUILLOTEAU D FARDE L
Citation: J. Sandell et al., PRECURSOR SYNTHESIS, RADIOLABELING AND PET EXAMINATION IN MONKEY OF 3POTENT SEROTONIN TRANSPORTER RADIOLIGANDS, The Journal of nuclear medicine, 39(5), 1998, pp. 469-469

Authors: HELFENBEIN J BOTTLAENDER M COULON C EDMOND P OTTAVIANI M FUSEAU C CHALON S LOCH C FRANGIN Y GUILLOTEAU D MAZIERE B
Citation: J. Helfenbein et al., PHARMACOLOGICAL EVALUATION AND PET STUDIES OF BR-76-PE2BR, A HIGHLY SELECTIVE RADIOBROMINATED COCAINE ANALOG FOR QUANTITATION OF DOPAMINE UPTAKE SITES, The Journal of nuclear medicine, 39(5), 1998, pp. 1050-1050

Authors: EMOND P CHALON S GARREAU L DOGNON AM BODARD S FRANGIN Y BAULIEU JL BESNARD JC GUILLOTEAU D
Citation: P. Emond et al., A NEW IODINATED TROPANE DERIVATIVE (BETA-CDIT) FOR IN-VIVO DOPAMINE TRANSPORTER EXPLORATION - COMPARISON WITH BETA-CIT, Synapse, 26(1), 1997, pp. 72-80

Authors: EMOND P BOAZI M DUCHENE A CHALON S BESNARD JC GUILLOTEAU D FRANGIN Y
Citation: P. Emond et al., SYNTHESIS OF IODINATED AND RADIOIODINATED -2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL) NORTROPANE (BETA-CDIT) - A LIGAND FOR THE DOPAMINE TRANSPORTER, Journal of labelled compounds & radiopharmaceuticals, 39(9), 1997, pp. 757-772

Authors: CHALON S EMOND P THIERCELIN C BODARD S GARREAU L FRANGIN Y MAUCLAIRE L BESNARD JC GUILLOTEAU D
Citation: S. Chalon et al., ROP-2E-ENYL)-2-BETA-CARBOMETHOXY-3-BETA-(4'-METHYL PHENYL) NORTROPANEAS A SELECTIVE MARKER FOR THE DOPAMINE TRANSPORTER - VALIDATION IN A RAT MODEL OF PARKINSONS-DISEASE, The Journal of nuclear medicine, 38(5), 1997, pp. 279-279

Authors: GARREAU L EMOND P BELZUNG C GUILLOTEAU D FRANGIN Y BESNARD JC CHALON S
Citation: L. Garreau et al., RBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL)NORTROPANE (BETA-CDIT), A TROPANE DERIVATIVE - PHARMACOLOGICAL CHARACTERIZATION AS A SPECIFIC LIGAND FOR THE DOPAMINE TRANSPORTER IN THE RODENT BRAIN, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 467-474

Authors: EMOND P GARREAU L CHALON S BOAZI M CAILLET M BRICARD J FRANGIN Y MAUCLAIRE L BESNARD JC GUILLOTEAU D
Citation: P. Emond et al., SYNTHESIS AND LIGAND-BINDING OF NORTROPANE DERIVATIVES - N-SUBSTITUTED BETA-CARBOMETHOXY-3-BETA-(4'-IODOPHENYL)NORTROPANE AND L)-2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DISUBSTITUTED PHENYL)NORTROPANE - NEW HIGH-AFFINITY AND SELECTIVE COMPOUNDS FOR THE DOPAMINE TRANSPORTER, Journal of medicinal chemistry, 40(9), 1997, pp. 1366-1372

Authors: FELLAHI Y MANDIN D DUBOIS P OMBETTAGOKA JE GUENZET J CHAUMONT JP FRANGIN Y
Citation: Y. Fellahi et al., GROWTH-INHIBITION OF CRYPTOCOCCUS-NEOFORMANS BY ZINYL)-5-(1,2-DIARYLETHYL)-4,6-DICHIOROPYRIMIDINES - SYNTHESIS AND IN-VITRO STUDIES, European journal of medicinal chemistry, 31(1), 1996, pp. 77-81

Authors: EMOND P GARREAU L CHALON S BOAZI M FRANGIN Y BESNARD JC GUILLOTEAU D
Citation: P. Emond et al., THE BETA-CDIT, A NEW COCAINE CONGENER FOR DOPAMINE TRANSPORTER EXPLORATION WITH HIGH SPECIFICITY AND VALUABLE IN-VIVO KINETIC, The Journal of nuclear medicine, 37(5), 1996, pp. 853-853

Authors: FELLAHI Y DUBOIS P AGAFONOV V MOUSSA F OMBETTAGOKA JE GUENZET J FRANGIN Y
Citation: Y. Fellahi et al., SYNTHESIS AND CHARACTERIZATION OF A NEW PYRIMIDINE DERIVATIVE - 2-(3-CHLOROPHENYL)ETHYL]-2,4,6-TRICHLOROPYRIMIDINE, Bulletin de la Societe chimique de France, 133(9), 1996, pp. 869-874

Authors: RAFII H CHALON S OMBETTA JE FRANGIN Y POURCELOT L BESNARD JC BODARD S GUILLOTEAU D
Citation: H. Rafii et al., AN IODINATED DERIVATIVE OF MOCLOBEMIDE AS POTENTIAL RADIOLIGAND FOR BRAIN MAO-A EXPLORATION, Life sciences, 58(14), 1996, pp. 1159-1169

Authors: LENA I OMBETTA JE CHALON S DOGNON AM BAULIEU JL FRANGIN Y GARREAU L BESNARD JC GUILLOTEAU D
Citation: I. Lena et al., IODODERIVATIVE OF PARGYLINE - A POTENTIAL TRACER FOR THE EXPLORATION OF MONOAMINE-OXIDASE SITES BY SPECT, Nuclear medicine and biology, 22(6), 1995, pp. 727-736

Authors: RAFII H CHALON S OMBETTA JE FRANGIN Y GARREAU L DOGNON AM LENA I BODARD S VILAR MP BESNARD JC GUILLOTEAU D
Citation: H. Rafii et al., SYNTHESIS AND CHARACTERIZATION OF [I-125] N-(2-AMINOETHYL)-4-IODOBENZAMIDE SELECTIVE AS A MONOAMINE-OXIDASE-B INHIBITOR, Nuclear medicine and biology, 22(5), 1995, pp. 617-623

Authors: BRANGER C GARREAU L DOGNON AM FRANGIN Y CAILLET M OMBETTAGOKA JE CHALON S BESNARD JC GUILLOTEAU D
Citation: C. Branger et al., SYNTHESIS OF 4'-IODO-5-METHOXY-VALEROPHENONE O-(2-AMINOETHYL)OXIME ASAN AGENT FOR EXPLORATION OF SEROTONINERGIC TRANSPORTER, Nuclear medicine and biology, 22(2), 1995, pp. 157-164

Authors: BRANGER C GARREAU L FRANGIN Y CHALON S DUBOIS P DOGNON AM OMBETTAGOKA JE BESNARD JC GUILLOTEAU D
Citation: C. Branger et al., RADIOIODINATED ANALOGS OF XYLAMINE - N-(2-CHLOROETHYL)-N-ETHYL-2-[I-125]IODOBENZYLAMINE AND N,N-DIETHYL-2-[I-125]IODOBENZYLAMINE AS POTENTIAL TOOLS FOR MONOAMINE UPTAKE EXPLORATION BY SPECT, Journal of labelled compounds & radiopharmaceuticals, 36(7), 1995, pp. 685-699

Authors: FELLAHI Y DUBOIS P MANDIN D OMBETTAGOKA JE GUENZET J CHAUMONT JP FRANGIN Y
Citation: Y. Fellahi et al., SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF 2-SUBSTITUTED 5-(1,2-DIARYLETHYL)-4,6-DICHLOROPYRIMIDINE DERIVATIVES, European journal of medicinal chemistry, 30(7-8), 1995, pp. 633-639

Authors: TESSIER L PATAT F SCHMITT N LETHIECQ M FRANGIN Y GUILLOTEAU D
Citation: L. Tessier et al., SIGNIFICANCE OF MASS AND VISCOUS LOADS DISCRIMINATION FOR AN AT-QUARTZ BLOOD-GROUP IMMUNOSENSOR, Sensors and actuators. B, Chemical, 19(1-3), 1994, pp. 698-703

Authors: GALINIER E OMBETTA JE FRANGIN Y MERTENS J BESNARD JC GUILLOTEAU D
Citation: E. Galinier et al., RADIOLABELING OPTIMIZATION OF )-2,3-DIHYDRO-5-HYDROXY-5H-IMIDAZO[2,1-A]ISOINDOLE OR [I-125] IODO MAZINDOL - A POTENTIAL TOOL FOR SPECT EXPLORATIONS, Journal of labelled compounds & radiopharmaceuticals, 34(5), 1994, pp. 487-497

Authors: GARREAU L OMBETTA JE GALINIER E DOGNON AM CHALON S FRANGIN Y BESNARD JC GUILLOTEAU D
Citation: L. Garreau et al., NEW RADIOLIGANDS FOR THE EXPLORATION OF DOPAMINE UPTAKE SITES BY SPET- DEVELOPMENT OF DERIVATIVES OF MAZINDOL - STRUCTURE AFFINITY RELATIONSHIP, The Journal of nuclear medicine, 35(5), 1994, pp. 160000247-160000247

Authors: GALINIER E GARREAU L DOGNON AM OMBETTAGOKA JE FRANGIN Y CHALON S BESNARD JC GUILLOTEAU D
Citation: E. Galinier et al., SYNTHESIS OF HALOGENATED ANALOGS OF -2,3-DIHYDRO-5-HYDROXY-5H-IMIDAZO[2,1-A]-ISOINDOLE OR MAZINDOL FOR EXPLORATION OF THE DOPAMINE TRANSPORTER, European journal of medicinal chemistry, 28(12), 1993, pp. 927-933

Authors: RODIER N AGAFONOV V CENSE JM GALINIER E OMBETTA JE FRANGIN Y GUILLOTEAU D
Citation: N. Rodier et al., 5-(3-IODOPHENYL)-2,3-DIHYDRO-5-HYDROXY-5H -IMIDAZO[2,1-A]ISOINDOLE, Acta crystallographica. Section C, Crystal structure communications, 49, 1993, pp. 841-843

Authors: PELLEVOISIN C CHALON S ZOUAKIA A DOGNON AM FRANGIN Y BAULIEU JL BESNARD JC GUILLOTEAU D
Citation: C. Pellevoisin et al., COMPARISON OF 2 RADIOIODINATED LIGANDS OF DOPAMINE-D2 RECEPTORS IN ANIMAL-MODELS - IODOBENZAMIDE AND IODOETHYLSPIPERONE, Life sciences, 52(23), 1993, pp. 1851-1860

Authors: FOULON C GUILLOTEAU D BAULIEU JL RIBEIROBARRAS MJ DESPLANCHES G FRANGIN Y BESNARD JC
Citation: C. Foulon et al., ESTROGEN-RECEPTOR IMAGING WITH 17-ALPHA-[I-123]IODOVINYL-11-BETA-METHOXYESTRADIOL (MIVE2) .1. RADIOTRACER PREPARATION AND CHARACTERIZATION, International journal of radiation applicatons and instrumentation. Part B: Nuclear medicine and biology, 19(3), 1992, pp. 257-261
Risultati: 1-25 |